• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS® CK MB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS® CK MB Back to Search Results
Catalog Number 30421
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer in (b)(6) reported a falsely elevated result for an external quality control (eqa) sample in association with the vidas® ck mb assay (lot: 1006158480).The customer reported that for cycle 8, sample 1 the result was too high.The customer stated that eqa was performed once per month and the assay was repeated with similar results.There was no patient involvement as the event pertained to a quality control sample.The customer stated other testing was then performed on different analyzers at different labs.The biomérieux local application specialist requested samples from two different labs to cross check but high results were obtained.A biomérieux internal investigation will be initiated.
 
Manufacturer Narrative
An internal investigation was performed for a customer in south africa reporting a falsely elevated result for an external quality control (eqa sample "lancet - standton" cycle 8 number 1) sample in association with the vidas® ck mb assay (lot 1006158480).The customer did not submit the sample for evaluation.No sample analysis could be performed.A review of quality records confirmed there was no anomaly during the manufacturing, control and packaging processes, and no capa, or non-conformity recorded for vidas ckmb assay (lot 1006158480).Control chart analysis was performed on five internal samples (target: 44.9-16.1-40.1-74.2-109 ng/ml) on five different batches of vidas ckmb ref 30421 including the customer's (lot 1006158480/181111-0) the analysis showed that vidas ckmb ref 30421 lot 1006158480/181111-0 is in the trend of other batches.Complaint trending analysis showed no other complaint for vidas ckmb assay (lot 1006158480).In conclusion, the vidas ckmb ref 30421 lot 1006158480/181111-0 is within the expected performances.Without the customer's return sample, and as vidas ckmb lot 1006158480/181111-0 has expired, it is not possible to pursue further investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® CK MB
Type of Device
VIDAS® CK MB
Manufacturer (Section D)
BIOMERIEUX SA
chemin de l orme
marcy l etoile, rhone 69280,
FR 
MDR Report Key8286105
MDR Text Key136858753
Report Number8020790-2019-00007
Device Sequence Number1
Product Code JHX
Combination Product (y/n)N
PMA/PMN Number
K962549
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 03/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/11/2018
Device Catalogue Number30421
Device Lot Number1006158480
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/12/2018
Initial Date FDA Received01/29/2019
Supplement Dates Manufacturer Received02/13/2019
Supplement Dates FDA Received03/12/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-